3/2
01:05 pm
ocul
Ocular Therapeutix (OCUL) had its "outperform" rating reaffirmed by William Blair.
Low
Report
Ocular Therapeutix (OCUL) had its "outperform" rating reaffirmed by William Blair.
3/2
01:05 pm
ocul
Ocular Therapeutix (OCUL) had its "outperform" rating reaffirmed by William Blair.
Low
Report
Ocular Therapeutix (OCUL) had its "outperform" rating reaffirmed by William Blair.
2/20
05:29 am
ocul
Rating for OCUL
High
Report
Rating for OCUL
2/20
05:29 am
ocul
Rating for OCUL
High
Report
Rating for OCUL
2/18
08:13 am
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
Low
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $21.00 price target on the stock.
2/18
07:00 am
ocul
Rating for OCUL
Low
Report
Rating for OCUL
2/5
10:58 am
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
2/5
10:58 am
ocul
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
Ocular Therapeutix (NASDAQ:OCUL) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.